CD80 and Angiopoietin-like 4 in glomerulopathies

Slides:



Advertisements
Similar presentations
Figure 1 Schematic representation of idiopathic nephrotic syndrome,
Advertisements

Martine K.F. Docx 1 , Johan Vande Walle 2
Laurence H. Beck, Jr. , M. D. , Ph. D. , Ramon G. B. Bonegio, M. D
Volume 63, Issue 2, Pages (February 2003)
Increased expression of heparanase in overt diabetic nephropathy
Martine K.F. Docx 1 , Johan Vande Walle 2
Volume 63, Issue 2, Pages (February 2003)
Volume 72, Issue 3, Pages (August 2007)
Juan F. Mejia, Parker Hall, Kelsey M. Hirschi, Paul R
Volume 66, Issue 5, Pages (November 2004)
Volume 78, Issue 8, Pages (October 2010)
Urinary proteomics before and after extracorporeal circulation in patients with and without acute kidney injury  Fabienne Aregger, MD, Christiane Pilop,
Volume 82, Issue 7, Pages (October 2012)
Volume 125, Issue 5, Pages (November 2003)
Cell Physiol Biochem 2016;40: DOI: /
Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria  Dan Wang, Chunsun Dai, Yingjian Li, Youhua.
Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic.
Volume 129, Issue 3, Pages (September 2005)
Volume 65, Issue 1, Pages (January 2004)
Volume 80, Issue 12, Pages (December 2011)
Volume 85, Issue 3, Pages (March 2014)
Volume 88, Issue 4, Pages (October 2015)
Anti-ACTL7a antibodies: a cause of infertility
Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic.
Volume 72, Issue 4, Pages (August 2007)
Volume 92, Issue 2, Pages (August 2017)
C.B. Marshall, J.W. Pippin, R.D. Krofft, S.J. Shankland 
Volume 82, Issue 7, Pages (October 2012)
Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells  Guillermo Villegas, Bäerbel Lange-Sperandio,
Characterization of proteinuria and tubular protein uptake in a new model of oral L-lysine administration in rats  K. Thelle, E.I. Christensen, H. Vorum,
Volume 81, Issue 6, Pages (March 2012)
Volume 80, Issue 10, Pages (November 2011)
Volume 72, Issue 7, Pages (October 2007)
Pdlim2 is a novel actin-regulating protein of podocyte foot processes
Volume 84, Issue 2, Pages (August 2013)
Volume 56, Issue 3, Pages (September 1999)
Tubular NF-κB and AP-1 activation in human proteinuric renal disease
Volume 70, Issue 3, Pages (August 2006)
A new mouse model of immune-mediated podocyte injury
Xue-Hui Liu, Achim Aigner, Anton Wellstein, Patricio E. Ray 
Decreased renal ischemia–reperfusion injury by IL-16 inactivation
Volume 76, Issue 2, Pages (July 2009)
Volume 83, Issue 3, Pages (March 2013)
Serum-soluble urokinase receptor concentration in primary FSGS
Volume 63, Issue 4, Pages (April 2003)
Volume 67, Issue 5, Pages (May 2005)
Volume 69, Issue 5, Pages (March 2006)
Volume 95, Issue 3, Pages (March 2019)
Volume 59, Issue 4, Pages (April 2001)
Volume 55, Issue 2, Pages (February 1999)
Xue-Hui Liu, Achim Aigner, Anton Wellstein, Patricio E. Ray 
Volume 65, Issue 1, Pages (January 2004)
Regulatory interactions of αβ and γλ T cells in glomerulonephritis
Tarak Srivastava, Robert E. Garola, Joan M. Whiting, Uri S. Alon 
Volume 66, Issue 5, Pages (November 2004)
Volume 77, Issue 8, Pages (April 2010)
Volume 61, Issue 1, Pages (January 2002)
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
No complement receptor 1 stumps on podocytes in human glomerulopathies
Volume 64, Issue 4, Pages (October 2003)
IFN-τ inhibits IgE production in a murine model of allergy and in an IgE-producing human myeloma cell line  Mustafa G. Mujtaba, PhDa, Lorelie Villarete,
IL-12 affects Dermatophagoides farinae–induced IL-4 production by T cells from pediatric patients with mite-sensitive asthma  Takeshi Noma, MD, PhD, Izumi.
Volume 69, Issue 11, Pages (June 2006)
Volume 60, Issue 5, Pages (November 2001)
World Kidney Day 2016: Kidney Disease & Children
Volume 125, Issue 5, Pages (November 2003)
Pathogenesis of minimal change disease: hypotheses.
Volume 63, Issue 2, Pages (February 2003)
Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis  Eero O. Honkanen, Anna-Maija Teppo, Carola.
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Presentation transcript:

CD80 and Angiopoietin-like 4 in glomerulopathies Gabriel Cara-Fuentes M.D.; Alfons Segarra† M.D.; Changli Wei‡ M.D.; Heiman Wang B.S.; Eduardo H. Garin M.D. Division of Pediatric Nephrology - University of Florida – Gainesville, Fl. †Department of Nephrology – Vall D’Hebron Hospital - Barcelona, Spain ‡ Department of Internal Medicine – Rush University- Chicago, IL Abstract Results Background: Minimal change disease (MCD) is considered a podocytopathy. We have shown that in MCD there is an increased podocyte expression of CD80 that may mediate proteinuria. Recently, the hyposialylated form of angiopoietin-like 4 (Angptl4) secreted by podocytes has been also suggested to play a role in proteinuria in MCD in humans and in several animal models of focal segmental Glomerulosclerosis-FSGS- and membranous nephropathy-MN-. Objective: To determine the role of CD80 and Angptl4 as mediators of proteinuria in MCD and other glomerulopathies in humans. Methods: Patients. 31, 31 and 32 patients with biopsy-proven MCD, FSGS and MN respectively and 18 control subjects were included. Urinary and serum CD80 and Angptl4 were measured by Elisa. In vitro studies. Human podocytes were maintained in RPMI 1640 containing 10% fetal bovine serum (FBS), 1% insulin-transferrin-selenium-A supplement (Invitrogen, Carlsbad, CA), penicillin (100 U/mL) and streptomycin (100 μg/mL). Cells were grown at 33°C in 95% air, 5% CO2 and then converted to differentiated cells by incubating at 37°C for 10 to 14 days. Differentiated cells were kept in 1% FBS growth media for 16 h and then incubated with 15% of serum from MCD patients in relapse, MCD in remission and 1% FBS growth media. Podocyte expression of CD80 and Angptl4 were measured by Western-Blot analysis. 2-D gel electrophoresis. pI of Angptl4 was determined in urine of a MCD patient in relapse. Immunofluorescence (IF). Frozen tissue sections were stained for CD80 (anti-human polyclonal CD80 goat antibody, R&D system) and Angptl4 (XXX). Statistical analysis using Mann-Whitney U test to compare two groups and Wilcoxon matched-pairs signed rank test for comparison of paired groups. Correlation between proteinuria and CD80 and Angptl4 were calculated using Spearman correlation. Results: Urinary CD80 was increased in MCD patients during relapse compared to those in remission and to patients with active FSGS, MN and to control subjects. Serum CD80 was lower in patients with glomerulopathies during relapse compared to normal controls. Urinary Angptl4 was increased in patients with glomerulopathies compared to normal controls, but no differences were found amount different types of nephrotic syndrome. Serum Angptl4 was higher in normal controls compared to patients with glomerulopathies. Urinary CD80 correlated with proteinuria in MCD, FSGS and MN whereas urinary Angptl4 correlated with proteinuria in FSGS and MN but not in MCD. Angptl4 detected in urine of a MCD patient had a pI of 5.4. Human podocytes exposed to sera from MCD patients in relapse showed a significant increase in CD80 expression, but not Angtpl4, compared to those exposed to sera from MCD patients in remission. Glomerular Angptl4 expression by IF was increased in kidney tissue from MCD patients in remission compared to MCD in relapse and controls. Glomerular CD80 expression by IF was increased in MCD in relapse compared to controls. Urinary CD80 in different types of glomerulopathies Serum CD80 and Angptl4 in different types of glomerulopathies Urinary CD80 is increased in MCD patients during relapse compared to remission, and to those with active FSGS, MN and control subjects Serum CD80 was decreased in patients with nephrotic syndrome compared to controls, this difference was statistically significant in the FSGS group compared to controls Serum Angptl4 was decreased in patients with nephrotic syndrome compared to controls. This difference reached statistically significance in the MN group compared to controls Urinary Angptl4 in different types of glomerulopathies Immunofluorescences studies: CD80 and Angptl-4 in MCD in relapse and controls Urinary Angptl4 is increased in nephrotic patients with MCD, FSGS and MN during relapse compared to controls. No difference was found among patients with different types of nephrotic syndrome Angptl4 expression in kidney tissue (Angptl4: green; DAPI: blue) CD80 expression in kidney tissue (CD80: green; DAPI: blue) MCD MCD MCD MCD Control Control Control Control In vitro experiments – Human podocyte cultures 2-D gel electrophoresis CD80 expression, but not Angplt4, is increased in podocytes cultured with sera from MCD patients in relapse Urinary Angptl4 has a pI of 5.4 in MCD in relapse Conclusions Urinary CD80 excretion in MCD in relapse is likely due to CD80 overexpression by podocytes that seems to be related to the presence of a circulating factor. Urinary CD80 is increased in MCD during relapse compared to MCD during remission and to patients with FSGS and MN during relapse and control subjects, suggesting that CD80 may play a role in proteinuria in MCD. Urinary Angptl4 is increased in patients with MCD, FSGS and MN during relapse compared to same patients during remission of proteinuria and to control subjects. Increased urinary Angptl4 in MCD in relapse is likely due to increased glomerular filtration of serum angptll4. The source of urinary Angptl4 is unlikely to be the podocyte since a) podocytes do not show increased Angtpl4 expression when cultured with sera from MCD patients in relapse and b) glomerular Angptl4 expression is similar in MCD in relapse compared to controls. Urinary Angptl4 in MCD in relapse has a pI of 5.4. Therefore it seems unlikely to have any role on neutralizing negative charges at the glomerular basement membrane. While CD80 seems to play a role in proteinuria in MCD, Angptl4 detected in urine in MCD and other glomerulopathies appears to be the result, rather than the cause, of a leaky glomerular filtration barrier. # pI MW 40 5.48 66 45 5.43 59